[Federal Register Volume 61, Number 77 (Friday, April 19, 1996)]
[Notices]
[Pages 17304-17305]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-9688]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Vaccine Advisory Committee (NVAC), Subcommittee on
Vaccine Safety and the Advisory Commission on Childhood Vaccines (ACCV)
Subcommittee on Vaccine Safety; Subcommittee on Immunization Coverage;
and Subcommittee on Future Vaccines: Meetings
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following Federal advisory committee
meetings.
Name: National Vaccine Advisory Committee (NVAC).
Times and Dates: 8:30 a.m-2 p.m., May 6, 1996; 8:30 a.m.-1 p.m.,
May 7, 1996.
Place: Hubert H. Humphrey Building, Room 703A, 200 Independence
Avenue, SW, Washington, DC 20201.
Status: Open to the public, limited only by the space available.
Notice: In the interest of security, the Department has
instituted stringent procedures for entrance to the Hubert H.
Humphrey Building by non-government employees. Thus, persons without
a government identification card should plan to arrive at the
building each day either between 8 and 8:30 a.m. or 12:30 and 1 p.m.
so they can be escorted to the meeting. Entrance to the meeting at
other times during the day cannot be assured.
Purpose: The Committee shall advise and make recommendations to
the Director of the National Vaccine Program on matters related to
the Program responsibilities.
Matters to be Discussed: The Committee will receive a report
from the Subcommittee on Immunization Coverage on how responsibility
for immunization is shared, accountability for immunization under
managed care, and assimilating additions to the vaccine schedule; a
report from the joint Subcommittee on Vaccine Safety on adverse
[[Page 17305]]
events in adults; Vaccine Adverse Effects Registry update; varicella
vaccine; hepatitis A vaccine post-marketing surveillance; long-term
stable funding for the Large-Linked Database; discussion of the
draft NVAC paper on Vaccine Research Partnerships; serologic
correlates of DTaP protection; update on NVAC funding of unmet
needs; children's vaccine initiative; the immunization registry; the
NVPO directorship; and the NVAC committee nominations.
Name: Subcommittee on Vaccine Safety and the Advisory Commission
on Childhood Vaccines Subcommittee on Vaccine Safety.
Time and Date: 2:30 p.m.-5 p.m., May 6, 1996.
Place: Hubert H. Humphrey Building, Room 425A., 200 Independence
Avenue, SW, Washington, DC 20201.
Status: Open to the public, limited only by the space available.
Purpose: This joint ACCV/NVAC subcommittee will review issues
relevant to vaccine safety and adverse reactions to vaccines.
Matters to be Discussed: The Subcommittee will discuss the
report from the Task Force on Safer Childhood Vaccines interagency
working group; expanding the Vaccine Injury Compensation Program to
include adult immunizations and immunizations in special
populations; visibility of a trust fund and administrative
resources; and lessons from the swine flue experience.
Name: Subcommittee on Immunization Coverage.
Time and Date: 2:30 p.m.-5 p.m., May 6, 1996.
Place: Hubert H. Humphrey Building, Room 423A, 200 Independence
Avenue, SW, Washington, DC 20201.
Status: Open to the public, limited only by the space available.
Purpose: The Subcommittee on Immunization Coverage will identify
strategies and policy options by which to further improve the levels
of immunization coverage.
Matters to be Discussed: The Subcommittee will discuss financing
of an immunizations forum and prioritize findings from the forum,
and previous committee work.
Name: Subcommittee on Future Vaccines.
Time and Date: 2:30 p.m.-5 p.m., May 6, 1996.
Place: Hubert H. Humphrey Building, Room 405A, 200 Independence
Avenue, SW., Washington, DC 20201.
Status: Open to the public, limited only by the space available.
Purpose: The Subcommittee on Future Vaccines will develop policy
options and guide national activities which will lead to accelerated
development, licensure, and best use of new vaccines in the simplest
possible immunization schedules.
Matters to be Discussed: The Subcommittee will identify the
matrix of interactions and partnerships, via specific case studies;
describe the process of priority-setting by each of the members of
the vaccine research and development community, and define barriers
to new vaccine development.
Agenda items for each meeting are subject to change as
priorities dictate.
Contact Person for More Information: Gloria A. Kovach, Committee
Management Specialist, National Vaccine Program Office, CDC, 1600
Clifton Road, NE, M/S D50, Atlanta, Georgia 30333, telephone 404/
639-7250.
Dated: April 15, 1996.
John C. Burckhardt,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention (CDC).
[FR Doc. 96-9688 Filed 4-18-96; 8:45 am]
BILLING CODE 4163-18-M
